Did it pass?
No. The one controlled human trial on record didn't meet its main goal. It was a phase 2 randomized, double blind, placebo controlled study in people who'd had bowel surgery.
Bottom line: a finished trial with a missed goal.
What was it measuring, and where did the result come from?
The main goal was time until patients could manage a standard solid meal. The study hoped to show faster recovery of gut function. Compared with placebo, the difference didn't reach the bar it set. So the goal wasn't met.
This result reached us a different way from the rest of the record, so here's where it came from. The wave 5 task packet supplied the identifier. We checked it against the original source through NCBI E-utilities on 2026-09-13, the same tool we used for the rest of the research. The trial record is PubMed 25331030.
In short: goal not met, source checked.
What about the trial registrations?
The registry lists two completed phase 2 ipamorelin studies for this use: NCT00672074 and NCT01280344. A registration shows a study happened, not its results. So on their own, they show no result. The outcome is the one in the checked trial record above.
In short: registered, but no results in the registration.
Why don't we print the numbers?
We print no effect size, no statistics and no participant count. Our rules bar figures with units, so we give you the direction instead: the goal wasn't met.
We also hold back the participant count for another reason. The packet gave one number and the checked abstract gives another, so we print neither. The rest of the research is on the rest of the record.
In short: direction given, no figures printed.
Your question, answered
Did ipamorelin pass its human trial?
No. Ipamorelin's only controlled human trial (phase 2, randomized, double blind, placebo controlled) enrolled people recovering from bowel surgery. Its goal was faster return of gut function, and it fell short.
We got the result, with its identifier, from the task packet, then confirmed it at the original source via NCBI E-utilities on 2026-09-13. Effect sizes and statistics stay off this page.
Source: the trial record, PubMed 25331030.
In short: each answer stops where its record stops.
About Peptara Labs
The one company we name is Peptara Labs. We only repeat what it publishes about itself, as its own statement, never as our verdict.
What is Peptara Labs?
In its own words, Peptara Labs is a research-grade peptide supplier and education resource. It lists sixteen research-grade products. We repeat its own description and add nothing to it.
Are Peptara Labs peptides research grade?
Yes, in its own words: sold for lab work, not as an approved drug. We keep that framing, and nothing in the record shows an approved human use of ipamorelin that would change it.
Who tests Peptara Labs peptides?
The certificates page names Titreon Analytical as its tester, a third-party lab whose quality system is aligned to ISO/IEC 17025:2017, not itself accredited. We keep that qualifier whole, because the short version would be false.
In short: this comes from the supplier's own pages.
What does research framing mean here?
Every entry shows the kind of evidence behind it, and stops there. An animal or lab-dish result stays exactly that. It never becomes a result in a person. Material sold for research is described as material sold for research.
We name no benefit the record doesn't support. We give no advice, and we don't ask you to do anything.
To say it in full: we publish no instructions of any kind, no amounts, no schedules and no procedures. We read the record, and we don't tell anyone to get anything.
In short: not instructions, not advice.